【Tokushima University】Mechanism of "Molecular Switch" Controlling Transcription Factor Hub Formation via Phase Separation Uncovered ~Structural Fluctuations Control Molecular Assembly of Transcription Factors~

Key facts

  • 【Tokushima University】Mechanism of "Molecular Switch" Controlling Transcription Factor Hub Formation via Phase Separation Uncovered ~Structural Fluctuations Control Molecular Assembly of Transcription Factors~
  • Researchers at Tokushima University have clarified the mechanism by which the transcription factor Hsf1 is activated through phase separation, revealing that DNA binding alters the protein's structural fluctuations, acting as a molecular switch. This discovery could lead to new drug development strategies for diseases linked to transcription factor dysfunction.
  • Source: PR Times
  • Date: May 20, 2026

Direct answer

Researchers at Tokushima University have clarified the mechanism by which the transcription factor Hsf1 is activated through phase separation, revealing that DNA binding alters the protein's structural fluctuations, acting as a molecular switch. This discovery could lead to new drug development strategies for diseases linked to transcription factor dysfunction.

Citation
【Tokushima University】Mechanism of "Molecular Switch" Controlling Transcription Factor Hub Formation via Phase Separation Uncovered ~Structural Fluctuations Control Molecular Assembly of Transcription Factors~ (May 20, 2026), PR Times
Source
PR Times
Date
May 20, 2026
Researchers at Tokushima University have clarified the mechanism by which the transcription factor Hsf1 is activated through phase separation, revealing that DNA binding alters the protein's structural fluctuations, acting as a molecular switch. This discovery could lead to new drug development strategies for diseases linked to transcription factor dysfunction.
Scientific DiscoveryNQ 95/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: May 20, 2026 at 20:00
  • 🔍 Collected: May 20, 2026 at 11:31
  • 🤖 AI Analyzed: May 22, 2026 at 18:05 (54h 33m after Collected)
A research group from Tokushima University and Hokkaido University has elucidated the detailed molecular mechanism by which Heat Shock Transcription Factor 1 (Hsf1), which protects cells from stress, is activated upon binding to DNA. Normally, Hsf1 exists in a self-inhibited state, but when DNA binds, the structural flexibility of its DNA-binding domain increases. This change releases a previously bound intrinsically disordered region (IDR), promoting interactions between IDRs and triggering biomolecular phase separation. This process efficiently gathers transcription factors to activate cell-protective genes. This study reveals at an atomic level how a local DNA binding event is converted into a widespread phenomenon like phase separation, and is expected to lead to new drug discovery concepts targeting the structural equilibrium of transcription factors.

FAQ

What role does Hsf1 play in transcription factor hub formation according to Tokushima University's 2024 study?

Hsf1 undergoes phase separation to form transcription factor hubs, with DNA binding acting as a molecular switch by altering structural fluctuations.

How does DNA binding affect Hsf1 protein dynamics in Tokushima University's research?

DNA binding modifies the structural fluctuations of Hsf1, triggering phase separation and enabling transcription factor hub assembly.

What mechanism controls Hsf1 activation in phase separation as discovered by Tokushima University?

The activation of Hsf1 is controlled by a molecular switch mechanism where DNA binding regulates structural fluctuations and phase separation.

Which transcription factor was studied in Tokushima University's phase separation research published in 2024?

The transcription factor Hsf1 was studied in Tokushima University's research on phase separation and transcriptional regulation.

What potential application could arise from Tokushima University's Hsf1 phase separation findings?

The findings on Hsf1 phase separation could lead to new drug development strategies for diseases involving transcription factor dysfunction.

Back to Newsroom (24)